Neurology
FDA approves AstraZeneca and Ionis’s Wainua
December 22, 2023Medical Communications AstraZeneca, FDA, Ionis, Neurology, Wainua
AstraZeneca and Ionis have announced that the US Food and Drug Administration (FDA) has approved Wainua (eplontersen) for the treatment …
PharmaKure and Universiti Teknologi MARA (UiTM) partner for Alzheimer’s diagnosis research
December 13, 2023Medical Communications Alzheimer's disease, Neurology, PharmaKure, UiTM
PharmaKure and the faculty of pharmacy at the University Teknologi MARA (UiTM), Malaysia, have announced a research collaboration focusing on …
AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn
December 7, 2023Business Services AbbVie, Cerevel Therapeutics, Neurology, acquisition
AbbVie and Cerevel Therapeutics have announced an agreement in which AbbVie will acquire Cerevel Therapeutics for $45 per share, or …
Teva Pharmaceuticals shares phase 3 data for Ajovy as migraine treatment
December 6, 2023Research and Development Neurology, Teva Pharmaceuticals, ajovy, obesity
Teva Pharmaceuticals has announced data from a post hoc analysis of two phase 3 clinical studies around the effectiveness of …
British Medical Journal publishes letter calling on government to reduce rate of antidepressant prescribing
December 5, 2023Medical Communications British Medical Journal, Neurology, antidepressants, over-prescribing
A group of medical professionals and politicians have published an open letter in the British Medical Journal which calls on …
FDA accepts NDA for Karuna’s schizophrenia treatment
November 30, 2023Medical Communications FDA, Karuna Therapeutics, NDA, Neurology, schizophrenia
Karuna Therapeutics has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for …
Autifony announces global license and collaboration agreement with Jazz Pharmaceuticals
November 14, 2023Business Services Autifony, Neurology, collaboration, jazz pharmaceuticals, neurological disorders
Autifony Therapeutics has announced that it has entered an exclusive global licensing agreement with Jazz Pharmaceuticals for up to $770.5m, …
Halozyme and Acumen Pharmaceuticals enter collaboration for Alzheimer’s treatment
November 7, 2023Business Services Acumen Pharmaceuticals, Alzheimer's disease, Halozyme, Neurology, collaboration
Halozyme Therapeutics has announced a global collaboration and non-exclusive license with Acumen Pharmaceuticals, providing Acumen with access to Halozyme’s Enhanze …
Allyx Therapeutics shares phase 1a trial data for Alzheimer’s treatment
October 31, 2023Medical Communications Allyx Therpeutics, Alzheimer's disease, Neurology, clinical trial
Allyx Therapeutics has announced phase 1a single ascending dose study results at the 16th Clinical Trials on Alzheimer’s Disease (CTAD) …
Eisai shares new data for Leqembi for Alzheimer’s treatment
October 26, 2023Research and Development Alzheimer's, Biogen, Eisai, Neurology, lecanemab
Eisai and Biogen have announced that Eisai has shared new data for Leqembi (lecanemab-irmb) 100mg/mL injection for intravenous (IV) use …
Karuna Therapeutics submits NDA to FDA for schizophrenia treatment
September 29, 2023Medical Communications FDA, Karuna Therapeutics, Neurology, mental health, schizophrenia
Karuna Therapeutics has announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration …
Pharmanovia acquires CNS portfolio from Sanofi
September 20, 2023Medical Communications CNS, Neurology, Pharmanovia, Sanofi, acquisition
Pharmanovia has announced that it will expand its neurology portfolio with the acquisition of a selection of central nervous system …
Exscientia enters AI drug discovery collaboration with Merck KGaA
September 20, 2023Business Services AI, Exscientia, Immunology, Merck KGaA, Neurology, Oncology, collaboration, drug discovery
Exscientia has announced a new collaboration with Merck KGaA, Darmstadt, Germany, with a focus on the discovery of novel small …
Sun Pharma and Pharmazz enter license agreement for Tyvalzi in India
September 14, 2023Sales and Marketing License Agreement, Neurology, Pharmazz, Sun Pharma, Tyvalzi, sovateltide
Sun Pharma has announced that one of its wholly owned subsidiaries has entered into a license agreement with Pharmazz in …
Neurocrine Biosciences begins phase 1 study assessing NBI-1117570 in healthy adults
September 12, 2023Research and Development Neurocrine Biosciences, Neurology, Sosei Heptares, clinical trial
Sosei Heptares has announced that its partner, Neurocrine Biosciences, has initiated its phase 1 first-in-human clinical trial to assess the …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
